The cost of diabetes in France - PubMed (original) (raw)
Comparative Study
The cost of diabetes in France
A Triomphe et al. Health Policy. 1988.
Abstract
Within an economic framework it is possible to evaluate the direct cost of diabetes. In 1984, for 109 diabetics - 27 insulin-dependent patients (IDD) and 82 non-insulin-dependent patients (NIDD) - of the Paris area, the average cost of diabetes was 7711 francs (Fr) for the IDD and 5892 Fr for the NIDD. This cost is the sum of the medical visits, drugs and hospitalization. The medical expenditures of the NIDD is roughly the same as for the general population (6462 Fr). For the IDD, the main difference concerns the drug expenditures. Moreover, in 1984, there is more home-care than in 1978. Lastly, there is little difference between prescription use in the U.S. and in France. Such results allow us to discuss the reimbursement of the care needed for diabetics.
Similar articles
- The socio-economic cost of diabetic complications in France.
Triomphe A. Triomphe A. Diabet Med. 1991;8 Spec No:S30-2. doi: 10.1111/j.1464-5491.1991.tb02152.x. Diabet Med. 1991. PMID: 1825953 - Health care expenditures for people with diabetes mellitus, 1992.
Rubin RJ, Altman WM, Mendelson DN. Rubin RJ, et al. J Clin Endocrinol Metab. 1994 Apr;78(4):809A-809F. doi: 10.1210/jcem.78.4.8157701. J Clin Endocrinol Metab. 1994. PMID: 8157701 - The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?*.
Ricordeau P, Weill A, Vallier N, Bourrel R, Schwartz D, Guilhot J, Fender P, Allemand H. Ricordeau P, et al. Diabetes Metab. 2003 Nov;29(5):497-504. doi: 10.1016/s1262-3636(07)70063-0. Diabetes Metab. 2003. PMID: 14631326 - Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association. American Diabetes Association. Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Diabetes Care. 2008. PMID: 18308683 Review. - [Diabetes and heredity].
Froguel P, Passa P. Froguel P, et al. Rev Med Interne. 1991 Mar-Apr;12(2):123-7. doi: 10.1016/s0248-8663(05)81375-x. Rev Med Interne. 1991. PMID: 1852994 Review. French.
Cited by
- Prevalence and temporal pattern of hospital readmissions for patients with type I and type II diabetes.
Liu X, Liu Y, Lv Y, Li C, Cui Z, Ma J. Liu X, et al. BMJ Open. 2015 Nov 2;5(11):e007362. doi: 10.1136/bmjopen-2014-007362. BMJ Open. 2015. PMID: 26525716 Free PMC article. - Costs of diabetes. A methodological analysis of the literature.
Pagano E, Brunetti M, Tediosi F, Garattini L. Pagano E, et al. Pharmacoeconomics. 1999 Jun;15(6):583-95. doi: 10.2165/00019053-199915060-00006. Pharmacoeconomics. 1999. PMID: 10538331 - Direct and indirect costs of cardiovascular and cerebrovascular complications of type II diabetes.
MacLeod KM, Tooke JE. MacLeod KM, et al. Pharmacoeconomics. 1995;8 Suppl 1:46-51. doi: 10.2165/00019053-199500081-00010. Pharmacoeconomics. 1995. PMID: 10159003 Review. - Economic evaluations of type II diabetes.
Leese B. Leese B. Pharmacoeconomics. 1995;8 Suppl 1:23-7. doi: 10.2165/00019053-199500081-00006. Pharmacoeconomics. 1995. PMID: 10158999 Review. - Diabetes mellitus and the St Vincent Declaration. The economic implications.
Leese B. Leese B. Pharmacoeconomics. 1995 Apr;7(4):292-307. doi: 10.2165/00019053-199507040-00004. Pharmacoeconomics. 1995. PMID: 10155319 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical